Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06714903 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer

Name: Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer — clinical trial record (NCT06714903)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhaseNot specified

SponsorThe First Hospital of Jilin University

Started2024-07-15

View on ClinicalTrials.gov ↗

Record status

This record was last updated December 4, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

The First Hospital of Jilin University

86 trials monitored

See 2 trials at risk

Colorectal Cancer

2,904 trials monitored

See 127 trials at risk

The purpose of this observational study is to understand the effect of gut microbiota on the efficacy of immunotherapy in patients with metastatic colorectal cancer and to explore the specific mechanisms of this process. In this way, it provides new ideas for the clinical treatment of colorectal cancer.

Trial Details

NCT Number	NCT06714903
Lead Sponsor	The First Hospital of Jilin University
Conditions	Colorectal Neoplasms Malignant
Enrollment	50 participants
Start Date	2024-07-15
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-12-04